This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Papanicolaou, D. A. Articles by Nieman, L. K. Search for Related Content PubMed PubMed Citation Articles by Papanicolaou, D. A. Articles by Nieman, L. K.

Nighttime Salivary Cortisol: A Useful Test for the Diagnosis of Cushing’s Syndrome

Department of Internal Medicine (D.A.P.), Emory University, Atlanta, Georgia 30322; and Department of Nursing (N.M.), Warren Grant Magnuson Clinical Center, and Pediatric and Reproductive Endocrinology Branch (I.K., L.K.N.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Lynnette K. Nieman, M.D., Pediatric and Reproductive Endocrinology Branch, National Institutes of Health, Building 10, Room 9D42 MSC 1583, 10 Center Drive, Bethesda, Maryland 20892-1583. E-mail: niemanl{at}nih.gov.

Abstract

Clinical features such as weight gain, depression, hypertension, and menstrual irregularities, although common in the general population, may raise the possibility of Cushing’s syndrome. Up to 30% of urine cortisol and dexamethasone suppression screening tests may return an incorrect result, suggesting that better tests are needed. This study evaluated the utility of nighttime salivary cortisol measurement as a screening test for Cushing’s syndrome. We evaluated 139 inpatients and 4 outpatients with possible Cushing’s syndrome, 16 inpatients and 7 outpatients with other nonadrenal disorders, and 34 healthy outpatients. Using cut points that excluded all subjects without Cushing’s syndrome, we compared the sensitivity for the detection of Cushing’s syndrome of nighttime salivary cortisol levels (2330 and 2400 h for inpatients and bedtime for outpatients), simultaneous inpatient serum cortisol levels, and urine glucocorticoid excretion. An assay- specific inpatient 2400-h salivary cortisol or an outpatient bedtime salivary cortisol greater than 550 ng/dl (15.2 nmol/liter) identified 93% of patients with Cushing’s syndrome (confidence interval, 89–98%) and excluded all individuals without the disorder. Salivary cortisol measurements worked as well as plasma measurements and better than urine glucocorticoid excretion. We concluded that bedtime salivary cortisol measurement is a practical and accurate screening test for the diagnosis of Cushing’s syndrome.

This article has been cited by other articles:

				B. Masserini, V. Morelli, S. Bergamaschi, F. Ermetici, C. Eller-Vainicher, A. M. Barbieri, M. A. Maffini, A. Scillitani, B. Ambrosi, P. Beck-Peccoz, et al. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma Eur. J. Endocrinol., January 1, 2009; 160(1): 87 - 92. [Abstract] [Full Text] [PDF]

				C. A. Carrasco, J. Coste, L. Guignat, L. Groussin, M. A. Dugue, S. Gaillard, X. Bertagna, and J. Bertherat Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing's Disease J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4728 - 4734. [Abstract] [Full Text] [PDF]

				M. Groschl Current Status of Salivary Hormone Analysis Clin. Chem., November 1, 2008; 54(11): 1759 - 1769. [Abstract] [Full Text] [PDF]

				L. K. Nieman, B. M. K. Biller, J. W. Findling, J. Newell-Price, M. O. Savage, P. M. Stewart, and V. M. Montori The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1526 - 1540. [Abstract] [Full Text] [PDF]

				M. B. Elamin, M. H. Murad, R. Mullan, D. Erickson, K. Harris, S. Nadeem, R. Ennis, P. J. Erwin, and V. M. Montori Accuracy of Diagnostic Tests for Cushing's Syndrome: A Systematic Review and Metaanalyses J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1553 - 1562. [Abstract] [Full Text] [PDF]

				S. Kidambi, H. Raff, and J. W Findling Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome Eur. J. Endocrinol., December 1, 2007; 157(6): 725 - 731. [Abstract] [Full Text] [PDF]

				F. Pecori Giraldi, A. G. Ambrogio, M. De Martin, L. M. Fatti, M. Scacchi, and F. Cavagnini Specificity of First-Line Tests for the Diagnosis of Cushing's Syndrome: Assessment in a Large Series J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4123 - 4129. [Abstract] [Full Text] [PDF]

				S. K. Baid, N. Sinaii, M. Wade, D. Rubino, and L. K. Nieman Radioimmunoassay and Tandem Mass Spectrometry Measurement of Bedtime Salivary Cortisol Levels: A Comparison of Assays to Establish Hypercortisolism J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3102 - 3107. [Abstract] [Full Text] [PDF]

				S. Kidambi, J. M. Kotchen, C. E. Grim, H. Raff, J. Mao, R. J. Singh, and T. A. Kotchen Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks Hypertension, March 1, 2007; 49(3): 704 - 711. [Abstract] [Full Text] [PDF]

				G. Reimondo, B. Allasino, S. Bovio, P. Paccotti, A. Angeli, and M. Terzolo Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome Eur. J. Endocrinol., December 1, 2005; 153(6): 803 - 809. [Abstract] [Full Text] [PDF]

				R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984. [Abstract] [Full Text] [PDF]

				A. Viardot, P. Huber, J. J. Puder, H. Zulewski, U. Keller, and B. Muller Reproducibility of Nighttime Salivary Cortisol and Its Use in the Diagnosis of Hypercortisolism Compared with Urinary Free Cortisol and Overnight Dexamethasone Suppression Test J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5730 - 5736. [Abstract] [Full Text] [PDF]

				M. Terzolo, S. Bovio, A. Pia, P. A. Conton, G. Reimondo, C. Dall'Asta, D. Bemporad, A. Angeli, G. Opocher, M. Mannelli, et al. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma Eur. J. Endocrinol., August 1, 2005; 153(2): 307 - 315. [Abstract] [Full Text] [PDF]

				R. C W Ma, W. B. Chan, W. Y. So, P. C Y Tong, J. C N Chan, and C. C. Chow Carbamazepine and false positive dexamethasone suppression tests for Cushing's syndrome BMJ, February 5, 2005; 330(7486): 299 - 300. [Full Text] [PDF]

				M. Yaneva, H. Mosnier-Pudar, M.-A. Dugue, S. Grabar, Y. Fulla, and X. Bertagna Midnight Salivary Cortisol for the Initial Diagnosis of Cushing's Syndrome of Various Causes J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3345 - 3351. [Abstract] [Full Text] [PDF]

				J. W. Findling, H. Raff, and D. C. Aron The Low-Dose Dexamethasone Suppression Test: A Reevaluation in Patients with Cushing's Syndrome J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1222 - 1226. [Abstract] [Full Text] [PDF]

				G. Arnaldi, A. Angeli, A. B. Atkinson, X. Bertagna, F. Cavagnini, G. P. Chrousos, G. A. Fava, J. W. Findling, R. C. Gaillard, A. B. Grossman, et al. Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5593 - 5602. [Abstract] [Full Text] [PDF]

				A. M. Isidori, G. A. Kaltsas, S. Mohammed, D. G. Morris, P. Jenkins, S. L. Chew, J. P. Monson, G. M. Besser, and A. B. Grossman Discriminatory Value of the Low-Dose Dexamethasone Suppression Test in Establishing the Diagnosis and Differential Diagnosis of Cushing's Syndrome J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5299 - 5306. [Abstract] [Full Text] [PDF]

				P. Putignano, P. Toja, A. Dubini, F. P. Giraldi, S. M. Corsello, and F. Cavagnini Midnight Salivary Cortisol Versus Urinary Free and Midnight Serum Cortisol as Screening Tests for Cushing's Syndrome J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4153 - 4157. [Abstract] [Full Text] [PDF]

				M. O. van Aken, J. A. Romijn, J. A. Miltenburg, and E. G.W.M. Lentjes Automated Measurement of Salivary Cortisol Clin. Chem., August 1, 2003; 49(8): 1408 - 1409. [Full Text] [PDF]

				E. V. Dimaraki and C. A. Jaffe Troglitazone Induces CYP3A4 Activity Leading to Falsely Abnormal Dexamethasone Suppression Test J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3113 - 3116. [Abstract] [Full Text] [PDF]

				H. Raff and J. W. Findling A Physiologic Approach to Diagnosis of the Cushing Syndrome Ann Intern Med, June 17, 2003; 138(12): 980 - 991. [Full Text] [PDF]

				H. Raff, P. J. Homar, and D. P. Skoner New Enzyme Immunoassay for Salivary Cortisol Clin. Chem., January 1, 2003; 49(1): 203 - 204. [Full Text] [PDF]